MSD
The Principal Scientist provides US and ex-US outcomes research support for Oncology programs focusing on Precision Medicine within the Value and Implementation organization. The role involves leading evidence generation methods for translational oncology studies, designing observational and real-world studies, and communicating findings to internal and external stakeholders. This position supports the implementation of the RWE capability maturity model and contributes to value evidence plans demonstrating clinical, economic, and patient-centered value.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Associate Principal Scientist/Associate Director, V&I Outcomes Research, HIV
Merck & Co., Inc.
Director, US Real-World Evidence & Health Outcomes Research Scientist Hematology-Oncology
GSK plc
Director, Global Real-World Evidence & Health Outcomes Research Scientist
GSK plc
Associate Director, Outcomes Research, Oncology Precision Medicine
Merck & Co., Inc.
Senior Epidemiologist, Inflammation, RWE & Regulatory Strategy (FSP Sponsor Dedicated)
IQVIA
Associate Director, Outcomes Research, Oncology Precision Medicine
Merck & Co., Inc.